Assessing Biotech Drivers, Performance In Australia And New Zealand
This article was originally published in PharmAsia News
Executive Summary
Panelists from the ASX Group, Australian Stockbroking companies Morgans and Paterson’s Securities discussed what biotech companies can do better to access capital from lucrative capital markets at the Australia Biotech Invest Conference Dec. 3 and 4, 2014.